CPRX vs. CL
Compare and contrast key facts about Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL).
Performance
CPRX vs. CL - Performance Comparison
Loading graphics...
CPRX vs. CL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 6.08% | 11.84% | 24.15% | -9.62% | 174.74% | 102.69% | -10.93% | 95.31% | -50.90% | 272.38% |
CL Colgate-Palmolive Company | 8.52% | -10.98% | 16.57% | 3.78% | -5.44% | 2.08% | 27.17% | 18.60% | -19.19% | 17.88% |
Fundamentals
CPRX:
$3.15B
CL:
$68.58B
CPRX:
$1.68
CL:
$2.63
CPRX:
14.71
CL:
32.41
CPRX:
0.26
CL:
8.37
CPRX:
5.35
CL:
3.39
CPRX:
3.30
CL:
1.27K
CPRX:
$588.99M
CL:
$20.38B
CPRX:
$726.82M
CL:
$12.25B
CPRX:
$257.78M
CL:
$3.77B
Returns By Period
In the year-to-date period, CPRX achieves a 6.08% return, which is significantly lower than CL's 8.52% return. Over the past 10 years, CPRX has outperformed CL with an annualized return of 35.35%, while CL has yielded a comparatively lower 4.23% annualized return.
CPRX
- 1D
- 4.12%
- 1M
- 7.28%
- YTD
- 6.08%
- 6M
- 25.69%
- 1Y
- 2.10%
- 3Y*
- 14.30%
- 5Y*
- 40.58%
- 10Y*
- 35.35%
CL
- 1D
- -0.58%
- 1M
- -14.03%
- YTD
- 8.52%
- 6M
- 7.99%
- 1Y
- -6.80%
- 3Y*
- 6.78%
- 5Y*
- 4.08%
- 10Y*
- 4.23%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CPRX vs. CL — Risk / Return Rank
CPRX
CL
CPRX vs. CL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CPRX | CL | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.06 | -0.32 | +0.38 |
Sortino ratioReturn per unit of downside risk | 0.32 | -0.32 | +0.64 |
Omega ratioGain probability vs. loss probability | 1.04 | 0.96 | +0.08 |
Calmar ratioReturn relative to maximum drawdown | 0.01 | -0.29 | +0.30 |
Martin ratioReturn relative to average drawdown | 0.02 | -0.51 | +0.52 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| CPRX | CL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.06 | -0.32 | +0.38 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.85 | 0.22 | +0.62 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.56 | 0.22 | +0.35 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.08 | 0.42 | -0.35 |
Correlation
The correlation between CPRX and CL is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
CPRX vs. CL - Dividend Comparison
CPRX has not paid dividends to shareholders, while CL's dividend yield for the trailing twelve months is around 2.44%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CL Colgate-Palmolive Company | 2.44% | 2.61% | 2.18% | 2.40% | 2.36% | 2.10% | 2.05% | 2.48% | 2.79% | 2.11% | 2.37% | 2.25% |
Drawdowns
CPRX vs. CL - Drawdown Comparison
The maximum CPRX drawdown since its inception was -94.25%, which is greater than CL's maximum drawdown of -58.91%. Use the drawdown chart below to compare losses from any high point for CPRX and CL.
Loading graphics...
Drawdown Indicators
| CPRX | CL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.25% | -58.91% | -35.34% |
Max Drawdown (1Y)Largest decline over 1 year | -27.29% | -20.74% | -6.55% |
Max Drawdown (5Y)Largest decline over 5 years | -45.37% | -29.05% | -16.32% |
Max Drawdown (10Y)Largest decline over 10 years | -64.87% | -29.05% | -35.82% |
Current DrawdownCurrent decline from peak | -5.89% | -18.85% | +12.96% |
Average DrawdownAverage peak-to-trough decline | -52.51% | -11.22% | -41.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.10% | 11.69% | +3.41% |
Volatility
CPRX vs. CL - Volatility Comparison
Catalyst Pharmaceuticals, Inc. (CPRX) has a higher volatility of 10.39% compared to Colgate-Palmolive Company (CL) at 6.68%. This indicates that CPRX's price experiences larger fluctuations and is considered to be riskier than CL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| CPRX | CL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.39% | 6.68% | +3.71% |
Volatility (6M)Calculated over the trailing 6-month period | 23.71% | 15.89% | +7.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 34.96% | 21.34% | +13.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.24% | 18.30% | +29.94% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 62.81% | 19.52% | +43.29% |
Financials
CPRX vs. CL - Financials Comparison
This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Colgate-Palmolive Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities